Auriculotherapy for Pre-Operative Anxiety in Kidney Surgery

This study is looking at whether auriculotherapy, a treatment involving stimulating points on the ear, can help reduce anxiety before surgery and potentially lower the need for pain medication afterward. You might be able to join if you are at least 18 years old, are scheduled for an elective partial or full kidney removal (nephrectomy) for cancer, and have a specific level of anxiety (anxiety score between 19 and 29 on a special questionnaire). The study is comparing an active auriculotherapy device (with nitrogen gas) to a placebo device (without nitrogen gas). Researchers will measure how much pain medication (opioids) you use from the day of surgery until discharge or up to 30 days later to see if the treatment is successful. The current recruitment status is unclear.

Study design
This is a randomized, placebo-controlled study planning to enroll 60 participants. Participants will be randomly assigned to receive either the active auriculotherapy treatment or a placebo treatment.
What's involved
You would complete questionnaires before surgery. The auriculotherapy treatment involves placing a device on specific points on your ear for a short time.
Compensation
Not stated in the trial record.
Follow-up
Researchers will track your opioid consumption from the day of surgery through discharge or up to 30 days post-operation, whichever comes first.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04836936

Auriculotherapy in the Treatment of Pre-Operative Anxiety

Active, Not Recruiting
NAAges 18+InterventionalTreatment
Jacques E. Chelly
~60 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:Auriculotherapy cryopuncture device without nitrogen gasAuriculotherapy cryopuncture device with nitrogen gas

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Opioid Consumption
Measured over Day of surgery through discharge or post-operative day 30, whichever came first
Anxiety Preoperative

NCT04836936

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • UPMC Shadyside Hospital

    Pittsburgh, Pennsylvaniano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Jacques E Chelly, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Greater than 18 years of age
Scheduled to undergo partial or full elective nephrectomy
Subject is willing and able to provide informed consent
Anxiety score ≥ 19 and ≤ 29 on the PROMIS Emotional Distress-Anxiety-Short Form 8a.

Exclusion

Opioid dependence, based on the DSM definition of Opioid Use Disorder (OUD)
Chronic pain condition where daily opioid use is needed
History of fibromyalgia
Anatomical malformation of ear (genetic or trauma-induced)
Vasculopathy of ear
Raynaud's disease
Patient Refusal
  • Opioid ConsumptionDay of surgery through discharge or post-operative day 30, whichever came first

    Demonstrate how auriculotherapy using the cryopuncture device changes participant's total opioid consumption following nephrectomy surgery.